Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Refeeding Syndrome in Oncology: Report of Four Cases.

Windpessl M, Mayrbaeurl B, Baldinger C, Tiefenthaller G, Prischl FC, Wallner M, Thaler J.

World J Oncol. 2017 Feb;8(1):25-29. doi: 10.14740/wjon1007w. Epub 2017 Feb 23.

2.

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.

Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF; Austrian Breast and Colorectal Cancer Study Group.

Lancet. 2015 Aug 1;386(9992):433-43. doi: 10.1016/S0140-6736(15)60995-3. Epub 2015 May 31.

PMID:
26040499
3.

Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial.

Eisterer W, De Vries A, Öfner D, Rabl H, Koplmüller R, Greil R, Tschmelitsch J, Schmid R, Kapp K, Lukas P, Sedlmayer F, Höfler G, Gnant M, Thaler J; Austrian Breast and Colorectal Cancer Study Group (ABCSG).

Anticancer Res. 2014 Nov;34(11):6767-73.

PMID:
25368289
4.

Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study.

Ofner D, Devries AF, Schaberl-Moser R, Greil R, Rabl H, Tschmelitsch J, Zitt M, Kapp KS, Fastner G, Keil F, Eisterer W, Jäger R, Offner F, Gnant M, Thaler J; TAKO 05/ABCSG R-02 Trial Investigators.

Strahlenther Onkol. 2011 Feb;187(2):100-7. doi: 10.1007/s00066-010-2182-6. Epub 2011 Jan 21.

PMID:
21267531
5.

Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis.

Heibl C, Trommet V, Burgstaller S, Mayrbaeurl B, Baldinger C, Koplmüller R, Kühr T, Wimmer L, Thaler J.

Eur J Cancer Care (Engl). 2010 Sep;19(5):676-81. doi: 10.1111/j.1365-2354.2009.01115.x. Epub 2009 Aug 25. Review.

PMID:
19708941
6.

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R; ABCSG-12 Trial Investigators, Marth C.

N Engl J Med. 2009 Feb 12;360(7):679-91. doi: 10.1056/NEJMoa0806285. Erratum in: N Engl J Med. 2009 May 28;360(22):2379.

7.

Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group.

Kroiss R, Winkler V, Kalteis K, Bikas D, Rudas M, Tea M, Fuerhauser C, Muhr D, Cerny H, Glueck S, Petru E, Concin H, Kubista E, Oefner P, Wagner T; Austrian Hereditary Breast and Ovarian Cancer Group.

J Cancer Res Clin Oncol. 2008 Oct;134(10):1113-21. doi: 10.1007/s00432-008-0383-5. Epub 2008 Apr 8.

PMID:
18392852
8.

The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).

Taucher S, Steger GG, Jakesz R, Tausch C, Wette V, Schippinger W, Kwasny W, Reiner G, Greil R, Dubsky P, Poestlberger S, Tschmelitsch J, Samonigg H, Gnant M; Austrian Breast and Colorectal Cancer Study Group-07.

Breast Cancer Res Treat. 2008 Nov;112(2):309-16. Epub 2007 Dec 14.

PMID:
18080748
9.

Long-term results of dose density therapy in patients with aggressive lymphoma.

Fridrik MA, Hausmaninger H, Linkesch W, Greil R, Krieger O, Baldinger C, Klocker J, Pont J, Oberaigner W.

Ann Hematol. 2005 Apr;84(4):217-22. Epub 2004 Nov 6.

PMID:
15538568
10.

A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).

Kühr T, Burgstaller S, Apfelbeck U, Linkesch W, Seewann H, Fridrik M, Michlmayr G, Krieger O, Lutz D, Lin W, Pont J, Köck L, Abbrederis K, Baldinger C, Buder R, Geissler D, Hausmaninger H, Lang A, Zabernigg A, Duba C, Hilbe W, Eisterer W, Fiegl M, Greil R, Gastl G, Thaler J; Austrian CML Study Group.

Leuk Res. 2003 May;27(5):405-11.

PMID:
12620292
11.

Dose escalation of ara-c may improve response rates in a subgroup of chronic myeloid leukemia patients with poor response to interferon-alpha and low-dose ara-C.

Hilbe W, Kühr T, Apfelbeck U, Fridrik M, Seewann H, Stöger M, Linkesch W, Pont J, Baldinger C, Hartner E, Bernhart M, Geissler D, Krieger O, Lang A, Lin W, Ludwig H, Duba C, Greil R, Gast G, Thaler J.

Leuk Lymphoma. 2001 Nov-Dec;42(6):1283-8.

PMID:
11911409
12.

[Fracture and embolization of a central venous port catheter without prior compression between the clavicle and the 1st rib].

Lenglinger FX, Hartl P, Kirchgatterer A, Lenglinger GM, Baldinger C.

Wien Klin Wochenschr. 2001 Feb 15;113(3-4):134-7. German.

PMID:
11253740
13.

Portal hypertension due to traumatic hepatic arterioportal fistula: report of successful embolization.

Kirchgatterer A, Baldinger C, Lenglinger F, Fröhler W, Meindl S, Zisch R, Kramar R.

Eur J Gastroenterol Hepatol. 1998 Dec;10(12):1057-9.

PMID:
9895055
14.

Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemia.

Hilbe W, Apfelbeck U, Fridrik M, Bernhart M, Niessner H, Abbrederis K, Michlmayr G, Pont J, Linkesch W, Hausmaninger H, Arneitz K, Baldinger C, Duba C, Eisterer W, Greil R, Konwalinka G, Niederwieser D, Gastl G, Thaler J.

Leuk Res. 1998 Oct;22(10):881-6.

PMID:
9766747
15.

[AL amyloidosis--a hematologic disease with initial cardiac manifestation. 2 case reports].

Berent R, Auer J, Punzengruber C, Oppitz P, Baldinger C, Kramar R, Pachinger O.

Z Kardiol. 1998 Jun;87(6):487-91. German.

PMID:
9691420
16.

First-line treatment of Waldenström's disease with cladribine. Arbeitsgemeinschaft Medikamentöse Tumortherapie.

Fridrik MA, Jäger G, Baldinger C, Krieger O, Chott A, Bettelheim P.

Ann Hematol. 1997 Jan;74(1):7-10.

PMID:
9031608
17.

Parameters of prognostic relevance to the patency of vascular access in hemodialysis patients.

Prischl FC, Kirchgatterer A, Brandstätter E, Wallner M, Baldinger C, Roithinger FX, Kramar R.

J Am Soc Nephrol. 1995 Dec;6(6):1613-8.

18.

[Spontaneous regression of a small cell bronchial carcinoma].

Roithinger FX, Wallner M, Baldinger C, Puchner R, Leitner L, Höbling W, Prischl FC.

Pneumologie. 1995 Sep;49(9):509-12. German.

PMID:
8532646
19.

Treatment of 11 patients with chronic myelogenous leukemia with interferon-alpha-2C and low-dose cytosine arabinoside.

Thaler J, Fluckinger T, Huber H, Lang A, Abbrederis C, Seewann H, Silly H, Baldinger C, Duba C, Huber C, et al.

Leuk Res. 1993 Aug;17(8):711-5.

PMID:
8355515
20.

Rupture of double lumen Hickman catheter at time of removal by surgery--another potentially serious complication.

Prischl FC, Mayr H, Ulbrich W, Wallner M, Baldinger C, Roithinger FX, Schwarz C, Fischlein T, Lugmayr H, Kramar R.

Nephron. 1993;64(1):153. No abstract available.

PMID:
8502324

Supplemental Content

Loading ...
Support Center